# US 2012/0238476 A1 · Alzheimer's disease diagnostic panels and methods for their use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0238476 A1
- Document ID: US20120238476A1
- Status: Published application
- Kind: A1
- Application number: 13/306,858
- Filed: 2011-11-29
- Published: 2012-09-20
- Earliest claimed: 2010-11-29
- Inventors: Xiao-Jun Li; Paul Kearney
- Web page: https://patentgrep.com/patent/US20120238476A1

## CPC

- G01N 33/6896: {Neurological disorders, e.g. Alzheimer's disease}
- G01N 2333/4703: Regulators; Modulating activity
- G01N 2333/775: Apolipopeptides
- G01N 2333/811: Serine protease (E.C. 3.4.21) inhibitors
- G01N 2333/91085: Transglutaminases; Factor XIIIq (2.3.2.13)
- G01N 2333/916: acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
- G01N 2800/2821: Alzheimer
- G01N 2800/60: Complex ways of combining multiple protein biomarkers for diagnosis
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Novel compositions, methods, assays and kits directed to a diagnostic panel for Alzheimer's disease are provided. In one embodiment, the diagnostic panel includes one or more proteins associated with Alzheimer's disease.

## Claims

### Claim 1

A diagnostic Alzheimer's disease panel comprising one or more proteins associated with Alzheimer's disease.
